arrow
Return

Medication effects on developmental sterol biosynthesis

delete2021-04-05
delete22
delete
OA
AI
Ž
Željka Korade
M
Marija Heffer
K
Károly Mirnics *
DOI:10.1038/s41380-021-01074-5delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Cholesterol is essential for normal brain function and development. Genetic disruptions of sterol biosynthesis result in intellectual and developmental disabilities. Developing neurons synthesize their own cholesterol, and disruption of this process can occur by both genetic and chemical mechanisms. Many commonly prescribed medications interfere with sterol biosynthesis, including haloperidol, aripiprazole, cariprazine, fluoxetine, trazodone and amiodarone. When used during pregnancy, these compounds might have detrimental effects on the developing brain of the offspring. In particular, inhibition of dehydrocholesterol-reductase 7 (DHCR7), the last enzyme in the biosynthesis pathway, results in accumulation of the immediate cholesterol precursor, 7-dehydrocholesterol (7-DHC). 7-DHC is highly unstable, giving rise to toxic oxysterols; this is particularly pronounced in a mouse model when both the mother and the offspring carry the Dhcr7(+/-) genotype. Studies of human dermal fibroblasts from individuals who carry DCHR7(+/-) single allele mutations suggest that the same gene*medication interaction also occurs in humans. The public health relevance of these findings is high, as DHCR7-inhibitors can be considered teratogens, and are commonly used by pregnant women. In addition, sterol biosynthesis inhibiting medications should be used with caution in individuals with mutations in sterol biosynthesis genes. In an age of precision medicine, further research in this area could open opportunities to improve patient and fetal/infant safety by tailoring medication prescriptions according to patient genotype and life stage.
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Molecular Psychiatry cover
Molecular Psychiatry
IF:
10.1
Papers:
7.3K
Citations:
3.9W

Organization

U
University of Nebraska Medical Center
Scholars:
8.0K
Papers: 5.8K
Citations: 1.1W
University of Nebraska System cover
University of Nebraska System
Scholars:
2.7W
Papers: 2.3W
Citations: 58